|
|
Article: Pharma business sold for $6.9 billion -- "BASF to focus more strongly on innovative chemistry, a highly efficient Verbund and a global presence".
- Article from:
- M2 Presswire
- Article date:
- December 15, 2000
CopyrightCOPYRIGHT 2000 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-15 December 2000-BASF: Pharma business sold for $6.9 billion -- "BASF to focus more strongly on innovative chemistry, a highly efficient Verbund and a global presence"
(C)1994-2000 M2 COMMUNICATIONS LTD
RDATE:15122000
Increasing BASF's financial flexibility
Accelerating the ongoing share buy-back program and reducing financial indebtedness
More than 50 percent of future sales to come from cyclically resilient operations BASF (NYSE: BF) is focusing on the strengths of its portfolio in order to broaden its base for further profitable growth.
That is why the world's biggest chemical company is selling its ...